Central Neurological System |
Neuron |
The symptomatology is related to a variety of sources of chronic neurological disturbance and associated distortions and chronicity in noxious sensory signaling and neuroimmune activation |
[9] |
Glial cells |
There is a significant blood–brain barrier permeability, microglia activation through toll-like receptors (TLR) signaling, secretion of IL-1B, upregulation of 5-HTT in astrocytes, reduced extracellular 5-HT levels, and hence a reduced activation of 5-HT receptors |
[10] |
Immune System |
Lymphocytes Th1/Th2 |
Significant bias toward Th2 immune responses in CFS patients leading to an effector memory cell bias toward type 2 responsiveness |
[11] |
NK cells |
Reduction of cytotoxic activity in CFS, leading to a higher susceptibility of infection |
[12] |
B cells |
Persistence of autoreactive cells that can generate autoantibodies during common infections |
[13] |
Endocrine System |
Hypothalamus–pituitary–adrenal (HPA) axis |
Enhanced corticosteroid-induced negative feedback, basal hypocortisolism, attenuated diurnal variation, and a reduced responsivity to challenge |
[14] |